Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|September 28, 2020
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With CyclosporinAlexandre Gérard, Serena Romani, Elise Van-Obberghen, et al.
Plos One|February 27, 2018
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinomaDamien Ambrosetti, Maeva Dufies, Bérengère Dadone, et al.
Molecular Oncology|February 22, 2023
A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinomaChristopher Montemagno, Jérôme Durivault, Cécile Gastaldi, et al.
JCO Oncology Practice|June 11, 2025
EMOTION: Assessing the Impact of a Telephone Intervention for Patients With Breast Cancer, a Randomized Controlled TrialSara Contu, Christophe Hebert, Jean-Marc Ferrero, et al.
Frontiers in Immunology|February 6, 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Jonathan Benzaquen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2022
Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective studyVictor Gaillard, Albane Lhuillier, Cécile Bigot, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2021
Immune checkpoint inhibitors-induced nephropathy: a French national surveyAlexandre O Gérard, Marine Andreani, Audrey Fresse, et al.
Cancer Treatment Reviews|May 20, 2021
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical dataPhilippe Barthélémy, Nathalie Rioux-Leclercq, Constance Thibault, et al.
BJU International|June 9, 2021
Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapyDamien Ambrosetti, Michael Coutts, Charlotte Paoli, et al.
The French Journal of Urology|October 10, 2025
Chemotherapy use in triplet approach for metastatic hormone-sensitive prostate cancer: French practice survey and expert opinionDelphine Borchiellini, Gwenaelle Gravis, Emmanuel Gross, et al.
Pageof 8